Related Experiment Videos
[The attempt to standardize treatment protocols for cancer-related hypercalcemia: developing a data-based flowchart]
Akira Shimada1, Toshimichi Nakaho, Ken Yazaki
1Tohoku University Hospital Palliative Care Center.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|January 10, 2004
Summary
This study presents a standardized flowchart for managing cancer-related hypercalcemia. Treatment is tailored to serum calcium levels and patient symptoms for optimal care.
Area of Science:
- Oncology
- Endocrinology
- Nephrology
Context:
- Cancer-related hypercalcemia is a frequent complication of malignancy.
- Existing treatment protocols lack standardization, leading to variable patient outcomes.
- Effective management requires a systematic approach based on calcium levels and clinical presentation.
Purpose:
- To develop a standardized treatment flowchart for cancer-related hypercalcemia.
- To stratify treatment protocols based on serum calcium concentration ranges.
- To integrate clinical evaluation of symptoms and disease progression into treatment decisions.
Summary:
- A flowchart for managing cancer-related hypercalcemia was developed from a review of existing literature.
- Treatment protocols were standardized across four serum calcium concentration ranges: <12 mg/dL, 12-14 mg/dL, 14-16 mg/dL, and >16 mg/dL.
- Within each calcium range, treatment was individualized based on patient symptoms and disease progression.
Impact:
- Provides a clear, evidence-based guideline for clinicians treating hypercalcemia in cancer patients.
- Aims to improve the consistency and efficacy of hypercalcemia management.
- Facilitates better patient outcomes by ensuring timely and appropriate interventions.